Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Le Page

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Revue Neurologique|May 26, 2018
Induction or escalation therapy for patients with multiple sclerosis?E Le Page, G Edan
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
International MS Journal|January 19, 2006
Mitoxantrone in the treatment of multiple sclerosisS P Morrissey, E Le Page, G Edan
Revue Neurologique|July 13, 2021
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based studyS Leblanc, J Roux, H Tillaut, et al.
Revue Neurologique|April 1, 2025
Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRI®) in France: An analysis of the PMSI database over five years (2019-2023)E Le Page, C Emery, A Fravalo, et al.
European Journal of Neurology|October 19, 2016
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?J Bonenfant, E Bajeux, V Deburghgraeve, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2012
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational studyE Leray, M Coustans, E Le Page, et al.
Revue Neurologique|March 7, 2006
[Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients]E Le Page, E Leray, G Taurin, et al.
Journal Francais D'Ophtalmologie|August 28, 2016
[Rapid improvement in visual function after high-dose oral corticosteroids in patients with inflammatory optic neuropathy]A Poujade, E Le Page, D Baudet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 26, 2011
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trialG Edan, G Comi, E Le Page, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Revue Neurologique|May 26, 2018
Induction or escalation therapy for patients with multiple sclerosis?E Le Page, G Edan
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 18, 2011
Long-term safety profile of mitoxantrone in a French cohort of 802 multiple sclerosis patients: a 5-year prospective studyE Le Page, E Leray, G Edan, et al.
International MS Journal|January 19, 2006
Mitoxantrone in the treatment of multiple sclerosisS P Morrissey, E Le Page, G Edan
Revue Neurologique|July 13, 2021
Disease-modifying therapy usage in patients with multiple sclerosis in France: A 6-year population-based studyS Leblanc, J Roux, H Tillaut, et al.
Revue Neurologique|April 1, 2025
Trends in the real-world management of patients with active relapsing-remitting multiple sclerosis treated with natalizumab (TYSABRI®) in France: An analysis of the PMSI database over five years (2019-2023)E Le Page, C Emery, A Fravalo, et al.
European Journal of Neurology|October 19, 2016
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?J Bonenfant, E Bajeux, V Deburghgraeve, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|August 4, 2012
'Clinically definite benign multiple sclerosis', an unwarranted conceptual hodgepodge: evidence from a 30-year observational studyE Leray, M Coustans, E Le Page, et al.
Revue Neurologique|March 7, 2006
[Mitoxantrone as induction therapy in aggressive relapsing remitting multiple sclerosis: a descriptive analysis of 100 consecutive patients]E Le Page, E Leray, G Taurin, et al.
Journal Francais D'Ophtalmologie|August 28, 2016
[Rapid improvement in visual function after high-dose oral corticosteroids in patients with inflammatory optic neuropathy]A Poujade, E Le Page, D Baudet, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|March 26, 2011
Mitoxantrone prior to interferon beta-1b in aggressive relapsing multiple sclerosis: a 3-year randomised trialG Edan, G Comi, E Le Page, et al.
Pageof 3